Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal

Psychopharmacology
Marc R AzarG. Schulteis

Abstract

Conditioned place aversion (CPA) is known to be a sensitive measure of the aversive motivational state produced by opioid withdrawal in rats made chronically dependent on opioids. The purpose of the present study was to examine the sensitivity of the CPA model in detecting a possible aversive state associated with naloxone-precipitated withdrawal from acute treatment with morphine. Doses of morphine and naloxone, as well as number of conditioning trials, were systematically varied to determine the minimum conditions that would result in a detectable CPA in male Wistar rats. Naloxone (0.003-16.7 mg/kg) was administered 4 h after an injection of vehicle or morphine (1.0, 3.3, or 5.6 mg/kg) and immediately prior to confinement to one compartment of the conditioning apparatus; rats received either one or two such naloxone-conditioning trials (separate by 48 h). Morphine (5.6 mg/kg) followed 4 h later by vehicle produced no significant preference or aversion. In morphine-naive rats, 10 mg/kg naloxone was required to produce a significant CPA with two cycles of conditioning. When increasing doses of morphine were administered (1.0, 3.3, 5.6 mg/kg), significant increases in naloxone potency to elicit a CPA were observed (16-, 211-, an...Continue Reading

Citations

Feb 8, 2005·Psychopharmacology·Andrew C Harris, Jonathan C Gewirtz
Feb 4, 2010·Psychopharmacology·Ginger L BeckerCharles P France
Aug 13, 2011·Psychopharmacology·Patrick E RothwellJonathan C Gewirtz
May 24, 2005·Pharmacology, Biochemistry, and Behavior·David A WhiteStephen G Holtzman
Jun 3, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Ying-Ying HeLin Lu
Jun 16, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·James R Shoblock, Nigel T Maidment
Feb 3, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Scott A ChenGeorge F Koob
Mar 4, 2008·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Shigeru IshidaYutaka Gomita
Apr 8, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Yan-qin LiLin Lu
Feb 22, 2012·Zoological Research·Yong-Mei SunJian-Hong Wang
Jun 23, 2010·Proceedings of the National Academy of Sciences of the United States of America·Stephen M TaubenfeldCristina M Alberini
May 4, 2010·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Stéphanie Perreau-LenzRainer Spanagel
Feb 9, 2010·Pharmacology, Biochemistry, and Behavior·Julia A Chester, Laran E Coon
Jan 20, 2009·Progress in Neuro-psychopharmacology & Biological Psychiatry·Alicia CabralVanessa M Castilho
Mar 1, 2008·Pharmacology, Biochemistry, and Behavior·Zhongqi Zhang, Gery Schulteis
Jul 6, 2007·The European Journal of Neuroscience·Hector Vargas-PerezDerek van der Kooy
Dec 2, 2004·Peptides·Richard J Bodnar, Gad E Klein
Aug 27, 2005·Pharmacology, Biochemistry, and Behavior·Gery SchulteisSally Tzeng

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.